Nav: Home

New US recommendation for diabetes screening may miss ethnic minority groups

July 12, 2016

In response to the worldwide diabetes epidemic, many countries are focusing healthcare efforts in order to improve evidence-based diabetes prevention and treatments. In 2015, the United States Preventive Services Task Force (USPSTF), an independent group of clinical experts whose work is supported by the U.S. government, issued a new recommendation to screen adults aged 40-70 years old who are overweight or obese for dysglycemia (a term used to describe those with either diabetes or prediabetes). In a study published in PLOS Medicine, as part of the Preventing Diabetes special issue which is Guest Edited by Professors Nick Wareham and William Herman, Matthew O'Brien (Northwestern University, USA) and colleagues present the results of their cohort analysis to determine the effectiveness of this screening program. Surprisingly, they show that this approach may only detect half of adults with undiagnosed dysglycemia; worryingly, this detection rate drops for racial or and ethnic minorities, compared to whites.

The authors conducted a retrospective analysis of electronic health records for 50,515 adult patients receiving primary care in 6 large community health centres in the Midwest and Southwest. Only 12,679 of the patients actually fulfilled the USPSTF criteria for screening. The authors show that of the 29,946 patients who completed a screening test within the three-year follow up period, 8,478 developed dysglycemia. Only 45% of these patients with dysglycemia would have been identified by the new USPSTF criteria. In addition, dysglycemia is less likely to be identified in minority patients. Among those who developed dysglycemia, the screening criteria detected 54.5% of whites, compared to 50.3% of Blacks and 37.7% of Hispanic/Latino patients. This difference reflects that more patients within these groups develop dysglycemia at a normal weight or aged under 40, relative to whites.

By reporting on the limited effectiveness of this screening program, this study raises concerns about the program's broad utility, particularly among racial and ethnic minority groups. Primary care providers may need to consider screening minority patients who are younger than 40 years old and have a normal weight. There may be economic consequences as health insurance providers may decide not to fund screening outside of this USPSTF recommendation, which could pass the full cost of testing onto patients.
-end-
Research Article

Funding:

We acknowledge the funders of this study: the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (K23DK095981; http://www.niddk.nih.gov/; MJO), the Agency for Healthcare Research and Quality (P01HS21141; http://www.ahrq.gov/), and the Chicago Center for Diabetes Translation Research (P30DK092949; http://chicagodiabetesresearch.org/pilot-and-feasibility-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests:

The authors have declared that no competing interests exist.

Citation:

O'Brien MJ, Lee JY, Carnethon MR, Ackermann RT, Vargas MC, Hamilton A, et al. (2016) Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients. PLoS Med 13(7): e1002074. doi:10.1371/journal.pmed.1002074

Author Affiliations:

Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
Center for Community Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
Alliance of Chicago Community Health Services, L3C, Chicago, Illinois, United States of America
Erie Family Health Center, Chicago, Illinois, United States of America
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States of America

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002074

Contact

Matthew O'Brien
Assistant Professor of Medicine
Northwestern University
Feinberg School of Medicine
750 N. Lake Shore Drive
Chicago, IL 60611
UNITED STATES
312-503-5046
matthew.obrien1@northwestern.edu

PLOS

Related Diabetes Articles:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.
Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.
Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).
Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.
Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

Kittens Kick The Giggly Blue Robot All Summer
With the recent passing of Ruth Bader Ginsburg, there's been a lot of debate about how much power the Supreme Court should really have. We think of the Supreme Court justices as all-powerful beings, issuing momentous rulings from on high. But they haven't always been so, you know, supreme. On this episode, we go all the way back to the case that, in a lot of ways, started it all.  Support Radiolab by becoming a member today at Radiolab.org/donate.